There is no abstract for this article. The text below is
the first paragraph of text within the article.
The development of a vaccine to prevent the build-up of
atherosclerotic plaque has come a step closer. Researchers at
the Cedars-Sinai Medical Center (Los Angeles, CA, USA) and
Lund University (Malmo, Sweden) have tested a peptide-based
vaccine that reduces arterial plaque formation in mice by up
to 70%
[1]. Developing effective
therapies for atherosclerosis is important because the disease
is the root cause of more than half of all deaths in the
developed world (
http://www.atherosclerosis-drug.com).
Full
Text Access